Remifentanil 1 MG vials
Ended Awarded
- Contract number
- SPE2DB25FB3KP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,939
Award facts
- Contract value 100% obligated
- $3,938.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,938.80 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Remifentanil 1 mg vials. The award was made without a set-aside designation, and performance is scheduled for completion by August 11, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent success in competing for DLA contracts covering an extensive portfolio of medications, biologics, and medical consumables. Remifentanil is a potent synthetic opioid commonly used in anesthesia and acute pain management within Department of Defense medical settings. The company's robust contract history reflects its established capability to deliver specialized pharmaceutical products directly to military health facilities, reinforcing its significant role in supporting federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FB3KP?
SPE2DB25FB3KP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FB3KP worth?
The government has obligated $3,939 on SPE2DB25FB3KP.
Is contract SPE2DB25FB3KP an order under another contract?
Yes. SPE2DB25FB3KP is a delivery order under SPE2DB20D9761, an indefinite delivery contract.
Was contract SPE2DB25FB3KP competed?
The extent of competition for SPE2DB25FB3KP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award